BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15792122)

  • 1. P53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up.
    Carlinfante G; Lazzaretti M; Ferrari S; Bianchi B; Crafa P
    Pathol Res Pract; 2005; 200(11-12):791-9. PubMed ID: 15792122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
    You JQ; Wang P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker.
    Mulay K; Puthyapurayil FM; Mohammad JA; Hasnat Ali M; Honavar SG; Reddy VA
    Histopathology; 2013 May; 62(6):840-6. PubMed ID: 23611357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of adenoid cystic carcinoma of minor salivary glands.
    Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical features of lacrimal gland epithelial tumors.
    Mendoza PR; Jakobiec FA; Krane JF
    Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
    Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
    Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
    Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of histological and biological features by serial passages in a human adenoid cystic carcinoma line transplantable in nude mice.
    Hashitani S; Noguchi K; Manno Y; Moridera K; Takaoka K; Nishimura N; Kishimoto H; Sakurai K; Urade M
    Oncol Rep; 2005 Apr; 13(4):607-12. PubMed ID: 15756431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
    Ramos Soler D; Navarro Fos S; Villamón Fort R; Gil Salom M; Llombart Bosch A
    Arch Esp Urol; 2003 Apr; 56(3):277-85. PubMed ID: 12768988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.